Investing

Terra Clean Provides Corporate Update

March 4, 2026
Investing

Fortune Bay Drills Multiple Gold Zones at Goldfields including 6.61 g/t over 5.0 m within 2.54 g/t over 17.0 m

March 4, 2026
Investing

Sankamap Announces $5.0M Private Placement

March 4, 2026
Investing

Brightstar Secures US$120M Bond to Fund Goldfields Project

March 4, 2026
Investing

Top 10 Copper Producers by Country

March 4, 2026
Politics

Trump exploring backing militias in Iran to topple weakened regime following strikes: reports

March 4, 2026
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Ted Butler: Silver’s Moment is Here, Time for...

July 15, 2025

Altech Batteries LtdCERENERGY Battery 46.7M Euro German Grant...

September 2, 2025

3 Key Themes from Fastmarkets’ 2025 Lithium Supply...

July 3, 2025

CoTec to Host Investor Update

January 14, 2026

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

May 28, 2025

High Copper Anomalies Show Deeper Potential at Warrego...

December 19, 2025

Locksley Resources LimitedAdvances Antimony Supply Strategy

September 10, 2025

Tech 5: US Lifts EDA Restrictions for China,...

July 6, 2025

Metro Mining

October 8, 2025

Lithium Market Forecast: Top Trends for Lithium in...

January 5, 2026